Bank of Montreal
BFRI icon

Bank of Montreal’s Biofrontera BFRI Stock Holding History

Bank of Montreal’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-750
Closed -$19 – 3973
2022
Q3 		$19 Sell
750
-500
-40% -$13.7K ﹤0.01% 3799
2022
Q2 		$62 Sell
1,250
-250
-17% -$15.2K ﹤0.01% 3574
2022
Q1 		$101K Hold
1,500
– – ﹤0.01% 3646
2021
Q4 		$240K Buy
+1,500
New +$164K ﹤0.01% 2876

Other funds holding BFRI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of Montreal's BFRI Position: Q4 2022 in Review

Bank of Montreal sold out of Biofrontera (BFRI) in Q4 2022, closing a stake of 750 shares — an estimated $19 sold.

Bank of Montreal first reported a position in BFRI in Q4 2021 and held it in 4 quarters. The position peaked at $240K in Q4 2021. 14 funds tracked by Wall St. Rank hold BFRI as of Q4 2022.

  • Bank of Montreal reported no remaining Biofrontera position as of Q4 2022 after selling out during the quarter.
  • Bank of Montreal sold 750 Biofrontera shares in Q4 2022, an estimated $19.
  • Bank of Montreal first reported a position in Biofrontera in Q4 2021 and held it in 4 quarters.
  • Bank of Montreal's Biofrontera position peaked at $240K in Q4 2021.
  • 14 funds tracked by Wall St. Rank held Biofrontera as of Q4 2022.

Based on Bank of Montreal's 13F filing for Q4 2022, filed 1 Feb 2023.